Fusemachines amends forward purchase agreement pricing; warrant exercise price cut to $10

Fusemachines Inc.

Forward Purchase Agreement Termination Price now adjusted weekly to lower of $12.00 or prior-week VWAP.
Two equal tranches have Reset Price Floors of $5.00 and $2.50.
Shortfall common stock purchase warrant exercise price reduced from $12.00 to $10.00 per share.
Amendments entered on February 3, 2026 with Meteora Capital Partners, Meteora Select Trading Opportunities Master, and Meteora Strategic Capital.
Original FPA dated July 31, 2025 provided for up to 3,000,000 shares in an OTC equity prepaid forward transaction.

item 1.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-005019
form_type: 8-K
ticker: FUSE
cik: 0002033383
company_name: Fusemachines Inc.
filed_at: 2026-02-04T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.064535+00:00
generated_at: 2026-05-16T05:05:46.970658+00:00
sec_items: ["1.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-005019
json_url: https://secwatch.observer/filing/0001493152-26-005019.json
markdown_url: https://secwatch.observer/filing/0001493152-26-005019.md
text_url: https://secwatch.observer/filing/0001493152-26-005019.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2033383/000149315226005019/0001493152-26-005019-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2033383/000149315226005019/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-005019

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.